Enhanced immune response to leukaemia.
D000941:Antigens / Q000032:analysis; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D007109:Immunity; D037102:Lectins; D007938:Leukemia / Q000188:drug therapy / Q000276:immunology* / Q000628:therapy*; D008214:Lymphocytes / Q000276:immunology; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D000941:Antigens; D000970:Antineoplastic Agents; D037102:Lectins; D014750:Vincristine; D011241:Prednisone; D008727:Methotrexate